Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Stockholm
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

MVIRB:SS

82.7500 SEK 1.0000 1.22%

As of 11:30:00 ET on 05/29/2015.

Snapshot for Medivir AB (MVIRB)

Open: 82.0000 Day's Range: 80.5000 - 82.7500 Volume: 79,375
Previous Close: 81.7500 52wk Range: 75.5000 - 140.9333 1-Yr Rtn: -29.77%

Stock Chart for MVIRB

No chart data available.
  • MVIRB:SS 82.7500
  • 1D
  • 1M
  • 1Y
81.7500
Interactive MVIRB Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for MVIRB

Current P/E Ratio (ttm) 2.9949
Estimated P/E(12/2015) 12.9804
Relative P/E vs. OMX 0.1829
Earnings Per Share (SEK) (ttm) 27.6300
Est. EPS (SEK) (12/2015) 6.3750
Est. PEG Ratio -
Market Cap (M SEK) 2,231.44
Shares Outstanding (M) 26.36
30 Day Average Volume 123,178
Price/Book (mrq) 1.5408
Price/Sale (ttm) 1.5336
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/20/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for MVIRB

  • Revenue
  • Net Income (M/SEK)
  • Profit Margin (%)

Company Profile & Key Executives for MVIRB

Medivir AB is a medical research company. The Company develops new drugs and pharmaceutical compounds based on proteases and polymerases as target enzymes. Medivir focuses on infectious and immunological diseases including projects against HIV, jaundice, shingles, multiple sclerosis, and rheumatoid arthritis. The Company is located in Huddinge, Sweden and Cambridge, United Kingdom.

Niklas PragerPresident/CEOOla BurmarkCFO
Christine LindExec VP:Strategic Business DevRichard BethellExec VP:Discovery Research
More Company Profile & Key Executives for MVIRB

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil